Clinical trials
Phase 3 Lymphoma, T-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aarhus University Hospital | 1 |
| Celgene | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Mundipharma (China) Pharmaceutical Co. Ltd | 1 |
| Peking Union Medical College Hospital | 1 |
| Seagen Inc. | 1 |
| Sichuan University | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
| University of Göttingen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 10 |
| Lymphoma, T-Cell, Peripheral | 4 |
| Lymphoma | 3 |
| Lymphoma, Large-Cell, Anaplastic | 3 |
| Immunoblastic Lymphadenopathy | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Hematologic Diseases | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoproliferative Disorders | 1 |
Trials
Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.